Testing tumour genetics in patients with cancers resistant to standard-of-care therapy
Not Applicable
- Conditions
- Cancer patients who are referred for an early-phase clinical trial.CancerCancer, early-phase clinical trial
- Registration Number
- ISRCTN42303887
- Lead Sponsor
- Greater Glasgow & Clyde NHS Board
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. Adult patients aged 18 years or over
2. Patients referred for an early-phase clinical trial with histologically confirmed advanced solid tumours
3. Patient meets one of the following criteria:
3.1. Willing and fit to have a tumour biopsy aimed at obtaining sufficient tissue for molecular profiling
3.2. Not willing/fit to have a tumour biopsy and had prior tumour molecular profiling
4. Patient deemed a suitable candidate for further systemic anti-cancer therapy
5. Willing and able to provide signed informed consent
Exclusion Criteria
Does not meet the inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method